KR910000101A - 효소형성 억제제 - Google Patents

효소형성 억제제 Download PDF

Info

Publication number
KR910000101A
KR910000101A KR1019890007597A KR890007597A KR910000101A KR 910000101 A KR910000101 A KR 910000101A KR 1019890007597 A KR1019890007597 A KR 1019890007597A KR 890007597 A KR890007597 A KR 890007597A KR 910000101 A KR910000101 A KR 910000101A
Authority
KR
South Korea
Prior art keywords
acid
unsaturated fatty
agent
medicament
salt
Prior art date
Application number
KR1019890007597A
Other languages
English (en)
Inventor
유다까 미시마
야스유끼 오오야마
마사시 구리모도
Original Assignee
유다까 미시마
하야시바라 겡
가부시기가이샤 하야시바라 세이부쓰 가가꾸 겡뀨우죠
진나이 쓰네오
산쇼오 세이야꾸 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13448188A external-priority patent/JP2684561B2/ja
Priority claimed from JP1222289A external-priority patent/JPH02193917A/ja
Application filed by 유다까 미시마, 하야시바라 겡, 가부시기가이샤 하야시바라 세이부쓰 가가꾸 겡뀨우죠, 진나이 쓰네오, 산쇼오 세이야꾸 가부시기가이샤 filed Critical 유다까 미시마
Publication of KR910000101A publication Critical patent/KR910000101A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

효소형성 억제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (15)

  1. 유효성분으로 아세트산, 락트산, 파부르산과 이들의 염 및 유도체에서 선택한 하나 또는 그 이상의 요소로 이루어짐을 특징으로 하는 티로시나제 형성을 자체에서 억제하는 약제.
  2. 제1항에 있어서, 아세트산, 락트산과 피루브산의 염이 조산, 락트산과 피르부산의 알카리 금속염과 알칼리토금속염임을 특징으로 하는 약제.
  3. 제1항에 있어서, 아세트산, 락트산과 피루부산의 유도체가 아세트산, 락트산과 피루부산의 에스테르와 산아미드임을 특징으로 하는 약제.
  4. 제1항에 있어서, 약제는 주사제, 정제, 캡슐, 연고, 로우션 또는 밀크로우션임을 특징으로 하는 약제.
  5. 제1항에 있어서, 약제가 향장품임을 특징으로 하는 약제.
  6. 제5항에 있어서, 향장품은 주사제, 정제, 캡슐, 연고, 배드솔트, 로우션, 밀크로우션, 팩 또는 크리임을 특징으로 하는 약제.
  7. 제1항에 있어서, 약제의 투약량이 0.01-1.000g/일/성인임을 특징으로 하는 약제.
  8. 제1항에 있어서, 약제가 불포화 지방산과 이들의 염 및 유도체에서 선택한 하나 또는 그 이상의 요소를 부가적으로 함유함을 특징으로 하는 약제.
  9. 제8항에 있어서, 불포화 지방산이 12-22개의 탄소원자를 갖는 것임을 특징으로 하는 약제.
  10. 제9항에 있어서, 12-22개의 탄소원자를 갖는 불포화 지방산이 라우토레산, 미리스톨레산, 펜타데세노산, 시스-9-헥사데네세노산, 올레산, 리놀레산, 리놀렌산,가돌레산, 아라키돈산, 4,8,12,16-아이코사테트라에노산, 5,8,11,14,17-아이코사펜타에노산, 에루크산과 클루파노돈산임을 특징으로 하는 약제.
  11. 제8항에 있어서, 불포화 지방산의 염이 불포화 지방산의 염이 불포화 지방산의 알카리 금속염과 알칼리토류 금속염임을 특징으로 하는 약제.
  12. 제8항에 있어서, 불포화 지방산의 유도체가 불포화 지방산의 에스테르와 산아미드임을 특징으로 하는 약제.
  13. 제8항에 있어서, 약제가 향장품임을 특징으로 하는 약제.
  14. 제13항에 있어서, 향장품이 주사제, 정제, 캡슐, 연고, 배드솔트, 로우션, 밀크로우션, 팩 또는 크리임을 특징으로 하는 약제.
  15. 제8항에 있어서, 약제의 투약량이 0.01-500g/일/성인임을 특징으로 하는 약제.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890007597A 1988-06-02 1989-06-02 효소형성 억제제 KR910000101A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13448188A JP2684561B2 (ja) 1988-06-02 1988-06-02 色素沈着抑制剤
JP88-134481 1988-06-02
JP1222289A JPH02193917A (ja) 1989-01-21 1989-01-21 酵素生成抑制剤
JP89-12222 1989-01-21

Publications (1)

Publication Number Publication Date
KR910000101A true KR910000101A (ko) 1991-01-29

Family

ID=26347793

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890007597A KR910000101A (ko) 1988-06-02 1989-06-02 효소형성 억제제

Country Status (2)

Country Link
EP (1) EP0345082A3 (ko)
KR (1) KR910000101A (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100327674B1 (ko) * 2000-01-20 2002-03-08 황분순 멜라닌성 색소집락의 감소 및 제거를 위한 피부 미화 청결제의 조성물
KR100643177B1 (ko) * 2004-11-27 2006-11-10 한국과학기술연구원 고체상 미량추출/기체 크로마토그래피/질량 분석기를이용한 시료 내 잔류 휘발성 유기 오염 물질의 검출 방법

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2593714B2 (ja) * 1989-09-20 1997-03-26 株式会社 林原生物化学研究所 色白剤
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5614561A (en) * 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5692302A (en) * 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
WO1993016690A1 (en) * 1992-02-25 1993-09-02 Warner-Lambert Company Cytoprotective compositions containing pyruvate and antioxidants
US5874463A (en) 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
EP0717984B1 (en) * 1994-12-20 2004-11-03 Unilever Plc Lactate dehydrogenase inhibitors in cosmetic compositions
KR100295561B1 (ko) * 1995-05-26 2001-08-07 알 브이 테이트 (로드니 비버스 테이트), 에이치 드로이. 씨. 지. 오닌크, 이. 에디, 산드라 웨드워즈 (에스 제이 에드워즈) 피부손상방지및교정용화장품
CA2221575A1 (en) * 1995-05-26 1996-11-28 Unilever Plc Treatment regime for skin
US6531116B1 (en) 1996-06-25 2003-03-11 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Treatment regime for skin
JP3639898B2 (ja) * 2001-09-26 2005-04-20 独立行政法人農業生物資源研究所 ブタ体外生産胚の体外培養用培養液及び該培養液を用いたブタ体外生産胚の体外培養方法
EP1494659B1 (en) * 2002-04-17 2005-10-12 Critical Therapeutics, Inc. Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
ES2397559T3 (es) 2009-03-09 2013-03-07 Unilever Nv Una composición cosmética para aclarar la piel
FR2997846B1 (fr) * 2012-11-09 2023-10-20 Oreal Composition comprenant un derive dicarbonyle et un acide, le procede de lissage des fibres keratiniques a partir de cette composition
US20210275418A1 (en) * 2020-03-09 2021-09-09 Colgate-Palmolive Company Personal Care Compositions
WO2021215709A1 (ko) * 2020-04-20 2021-10-28 주식회사 엘지생활건강 소듐 피루베이트를 유효성분으로 하는 미백 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781150A (en) * 1955-12-22 1957-08-14 Kisaku Ibe Cosmetic and hair tonic preparations
CH566780A5 (ko) * 1970-06-24 1975-09-30 Bristol Myers Co
IT1075741B (it) * 1977-04-19 1985-04-22 Porro Marcella Composizione per il trattamento di dermatosi iperpigmentarie
JPS567710A (en) * 1979-06-28 1981-01-27 Sansho Seiyaku Kk Whitening cosmetic
JPH064529B2 (ja) * 1985-03-20 1994-01-19 株式会社資生堂 皮膚外用剤
JP2533776B2 (ja) * 1987-05-14 1996-09-11 ポーラ化成工業株式会社 皮膚外用剤
JPS63284109A (ja) * 1987-05-15 1988-11-21 Sunstar Inc 美白化粧料

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100327674B1 (ko) * 2000-01-20 2002-03-08 황분순 멜라닌성 색소집락의 감소 및 제거를 위한 피부 미화 청결제의 조성물
KR100643177B1 (ko) * 2004-11-27 2006-11-10 한국과학기술연구원 고체상 미량추출/기체 크로마토그래피/질량 분석기를이용한 시료 내 잔류 휘발성 유기 오염 물질의 검출 방법

Also Published As

Publication number Publication date
EP0345082A3 (en) 1990-04-04
EP0345082A2 (en) 1989-12-06

Similar Documents

Publication Publication Date Title
KR910000101A (ko) 효소형성 억제제
KR910005847A (ko) 피부 백색제
RU94045141A (ru) Гетероциклические производные карбоновой кислоты и их соли и фармацевтическая композиция с антифибротической или тормозящей пролилгидроксилазу или биосинтез коллагена активностью
ATE386508T1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
EA200100895A1 (ru) Незаменимые жирные кислоты для предотвращения сердечно-сосудистых приступов
KR940018090A (ko) 트리글리세라이드
NZ217703A (en) 2-(2-fluoro-4-biphenylyl) propionic acid compositions
HK1030155A1 (en) Treatment of scar tissue using lipoic acid
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
KR910000102A (ko) 효소형성 억제제
Carey et al. The pattern of fatty acid synthesis in lactating rabbit mammary gland studied in vivo
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
KR880011139A (ko) 크로몬 유도체
KR900011470A (ko) 외용제
GB1097531A (en) Improvements in or relating to the preparation of cyclopentane derivatives
TW360545B (en) Dermatologic preparation
GB1395666A (en) Thiophene derivatives processes for their preparation and compositions incorporating them
GB1153670A (en) Isoquinoline Derivatives and preparation thereof
AU576548B2 (en) Acylated cytidine-diphosphate-choline derivatives
KR970706828A (ko) 경피 투여형 제제(percutaneously administrable preparation)
GB1514389A (en) Glycerides with antibacterial properties
GB1448547A (en) Derivative of phenylacetic acid
NZ214640A (en) Trienamide derivatives and pharmaceutical compositions having anti-inflammatory and analgesic activity
Veitch et al. Organic aciduria in rats made resistant to hypoglycin toxicity by pretreatment with clofibrate
GB1473574A (en) Sitosterol esters

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid